Author/Authors :
Martin، نويسنده , , Sarah A. and McCabe، نويسنده , , Nuala and Mullarkey، نويسنده , , Michelle and Cummins، نويسنده , , Robert and Burgess، نويسنده , , Darren J. and Nakabeppu، نويسنده , , Yusaku and Oka، نويسنده , , Sugako and Kay، نويسنده , , Elaine and Lord، نويسنده , , Christopher J. and Ashworth، نويسنده , , Alan، نويسنده ,
Abstract :
Summary
tic sickness/lethality (SSL) can be exploited to develop therapeutic strategies for cancer. Deficiencies in the tumor suppressor proteins MLH1 and MSH2 have been implicated in cancer. Here we demonstrate that deficiency in MSH2 is SSL with inhibition of the DNA polymerase POLB, whereas deficiency in MLH1 is SSL with DNA polymerase POLG inhibition. Both SSLs led to the accumulation of 8-oxoG oxidative DNA lesions. MSH2/POLB SSL caused nuclear 8-oxoG accumulation, whereas MLH1/POLG SSL led to a rise in mitochondrial 8-oxoG levels. Both SSLs were rescued by silencing the adenine glycosylase MUTYH, suggesting that lethality could be caused by the formation of lethal DNA breaks upon 8-oxoG accumulation. These data suggest targeted, mechanism-based therapeutic approaches.
